AKR1C3介导的脂肪雄激素生成驱动多囊卵巢综合征女性的脂毒性
该研究纳入10例多囊卵巢综合征(PCOS)女性和10例体重指数匹配的健康对照,进行人体深部代谢在体表型研究并结合体外实验。PCOS女性皮下脂肪组织中睾酮和二氢睾酮浓度及AKR1C3表达增加,急性雄激素暴露抑制脂肪分解,非靶向血清代谢组学显示雄激素仅促PCOS女性脂质生成。结论提示脂肪内雄激素活化参与PCOS脂肪重塑和全身脂毒性代谢组,AKR1C3为潜在治疗靶点。
要点
- PCOS女性皮下脂肪内睾酮(P=0.0006)和二氢睾酮(P=0.01)浓度升高。
- PCOS女性皮下脂肪AKR1C3表达增加(P=0.04)。
- 急性雄激素暴露后PCOS女性皮下脂肪微透析液甘油水平支持在体抑制脂解(P=0.04)。
核心结论
- 研究定义了脂肪内雄激素活化机制,该机制参与脂肪重塑和全身脂毒性代谢组,脂肪内雄激素驱动PCOS脂质蓄积和胰岛素抵抗。
- AKR1C3是PCOS有前景的治疗靶点。
研究设计与样本
- 人体深部代谢在体表型研究,纳入10例PCOS女性和10例体重指数匹配的健康对照,并辅以体外实验,检测急性和慢性雄激素暴露的全身及脂肪内效应。
主要发现
- PCOS女性皮下脂肪组织睾酮浓度(P=0.0006)和二氢睾酮浓度(P=0.01)增加,雄激素活化酶AKR1C3表达增加(P=0.04)。
- PCOS女性皮下脂肪微透析液甘油水平支持急性雄激素暴露后在体抑制脂解(P=0.04)。
- 非靶向血清代谢组学显示雄激素仅在PCOS女性中具有促脂质生成效应。
- 体外研究显示胰岛素增加脂肪AKR1C3表达和活性,而雄激素暴露增加脂肪细胞从头脂质合成。
- 体外药理学抑制AKR1C3减少从头脂质生成。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Polycystic ovary syndrome (PCOS) is a prevalent metabolic disorder occurring in up to 10% of women of reproductive age. PCOS is associated with insulin resistance and cardiovascular risk. Androgen excess is a defining feature of PCOS and has been suggested as causally associated with insulin resistance; however, mechanistic evidence linking both is lacking. We hypothesized that adipose tissue is an important site linking androgen activation and metabolic dysfunction in PCOS. METHODS: We performed a human deep metabolic in vivo phenotyping study examining the systemic and intra-adipose effects of acute and chronic androgen exposure in 10 PCOS women, in comparison with 10 body mass index-matched healthy controls, complemented by in vitro experiments. RESULTS: PCOS women had increased intra-adipose concentrations of testosterone (P = 0.0006) and dihydrotestosterone (P = 0.01), with increased expression of the androgen-activating enzyme aldo-ketoreductase type 1 C3 (AKR1C3) (P = 0.04) in subcutaneous adipose tissue. Adipose glycerol levels in subcutaneous adipose tissue microdialysate supported in vivo suppression of lipolysis after acute androgen exposure in PCOS (P = 0.04). Mirroring this, nontargeted serum metabolomics revealed prolipogenic effects of androgens in PCOS women only. In vitro studies showed that insulin increased adipose AKR1C3 expression and activity, whereas androgen exposure increased adipocyte de novo lipid synthesis. Pharmacologic AKR1C3 inhibition in vitro decreased de novo lipogenesis. CONCLUSIONS: These findings define an intra-adipose mechanism of androgen activation that contributes to adipose remodeling and a systemic lipotoxic metabolome, with intra-adipose androgens driving lipid accumulation and insulin resistance in PCOS. AKR1C3 represents a promising therapeutic target in PCOS.
引用
- O'Reilly MW, Kempegowda P, Walsh M, et al. AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2017. PMID: 28645211. doi:10.1210/jc.2017-00947
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。